July 20th, 2023
CanBiocin Receives Patent for its Innovative Wolf-Derived Probiotic for Dogs.
CanBiocin’s Probiotic Bacteria Isolated from Wolves and Related Compositions and Methods is a pioneering product that aims to enhance the overall health and well-being of canine companions by promoting a balanced and robust gut microbiome.
March 15th, 2023
CanBiocin Granted Sole License for Patented Microencapsulation Technology.
Microencapsulation patented process instrumental for protecting heat sensitive bioactive materials.
CanBiocin partnered with BioAlberta to participate in the WIL (Work Integrated Learning) Voucher program this past summer.
WIL experiences often provide unique opportunities for students to learn many different aspects of the business world, and they were able to provide that for, Christel G.
Dr. J.F. (Jake) Burlet, CEO
780 953 7997
December 7, 2021
CANBIOCIN ACHIEVES INTERNATIONAL ORGANIZATION FOR STANDARDIZATION (“ISO”) ACCREDITATION
CanBiocin accredited for ongoing commitment to quality assurance
EDMONTON, Alberta; December 7, 2021 – CanBiocin, creators of species-specific probiotics to support the health and productivity of companion animals and livestock, has successfully met the standard for ISO 17025 accreditation. ISO is an independent, non-governmental and international organization that certifies for standardization against global benchmarks for internal process controls and quality assurance.
"ISO accreditation is important for us both at home and internationally,” says CanBiocin CEO, Dr. J.F. (Jake) Burlet. “This accreditation is in the agriculture inputs, food, animal health and plant protection program specialty area”. ISO recognition of CanBiocin’s focus on quality, safety and efficiency of our products, services and systems is a credit to our dedicated scientists and staff who invested almost two years of effort to achieve this outcome.”.
ISO accreditation will help us grow and expand our international markets and gives our customers even greater confidence in our capabilities and expertise. Being recognized by ISO tells the marketplace that we have rigorous processes and systems in place to ensure consistency, quality and safety in all that we do.
CanBiocin is a global leader in species-specific companion animal and livestock probiotic development. With a mission to build health from the inside out, the company targets overall microbiome health to support animal wellness, vitality and productivity. Today, its premium canine and other pet probiotic lines help global pet food manufacturers fill their customers’ need to care for their pets as integral members of their families deserving of the same attention and investment in their health and wellness.
CanBiocin’s livestock probiotics offer a natural, non-antibiotic alternative to support
livestock health and production. Poultry and swine producers benefit by having healthier, productive animals. CanBiocin has a growing number of customers in North America, as well as internationally.
ISO certification certifies that a management system, manufacturing process, service, or documentation procedure has all the requirements for standardization and quality assurance. Each
certification has separate standards and criteria and is classified numerically. ISO requires organizations to define and follow a quality management system that is both appropriate and effective while also requiring them to identify areas for improvement and take action toward those improvements. More details on ISO accreditation can be found at www.iso.org.
CanBiocin Secures European Distribution of Proprietary Species-Specific Probiotics.
CanBiocin, creators of species-specific probiotics for companion animals, has aligned with Healy Group for market entry and distribution across the United Kingdom and Ireland. This partnership follows on CanBiocin’s submission for approval by the European Food Safety Authority (EFSA). In addition to published EFSA requirements, CanBiocin has completed significant additional third-party studies for safety and efficacy.
Please click below link to see more information:
Alberta, May 5, 2020
Shaping a new tomorrow for pet and livestock health.
Canadian Pet and Livestock Probiotic Leader CanBiocin Expands into U.S. with Acquisition
EDMONTON, Alberta; May 5, 2020 – Edmonton-based biotechnology company CanBiocin Inc. has acquired all of the assets of Denver, CO-based Pure Cultures Inc. effective April 30, 2020. CanBiocin produces species-specific probiotics to support pet and livestock health. Pure Cultures’ assets include proven species-specific probiotics, a U.S. patent for probiotics, and fermentation metabolites for the prevention and treatment of disease conditions in animals as well as products for poultry and pigs marketed under the brand names Flock Vitality® and Pig Vitality™. Deal terms were not disclosed.
“Pure Cultures’ founder and CEO Steve Kazemi has a shared vision and passion for improving pet and livestock health through enhanced nutrition backed by science and focusing on gut health,” said CanBiocin CEO Dr. J.F. (Jake) Burlet. “CanBiocin’s portfolio of species-specific probiotics support animal health by building health through the gut microbiome. The microbiome is the community of microorganisms residing in the intestinal tract and is responsible for digestion, metabolism, immune function and protecting against harmful bacteria,” says Burlet.
This acquisition firmly establishes CanBiocin operations in the U.S. Kazemi, a seasoned biotechnology veteran, joins CanBiocin as Chief Commercialization Officer.
“Pure Cultures has made significant investments in developing novel products to develop a healthy gut,” said Kazemi. “Our focus has been developing natural alternatives to curb or eliminate the use of antibiotics in livestock while improving productivity.”
CanBiocin successfully raised funds to close the transaction during the Covid-19 global pandemic; an unprecedented time of business uncertainty. “Our preparedness and willingness to explore all avenues for transaction funding allowed us to access the necessary liquidity for this deal,” stated Burlet.
Around the world, people have leaned on their pets for comfort and companionship during extended periods of self-isolation. The importance of supporting and bolstering animal health for pet family members has never been more front and center. CanBiocin, together with an expanded suite of species-specific probiotics sourced via this asset purchase from Pure Cultures, has clearly positioned itself as a global leader with deep subject matter expertise in microbiome support,” said Dr. Burlet.
Dr. J.F. (Jake) Burlet, CEO
780 953 7997
CanBiocin was founded in 1998 and is a global leader in species-specific companion animal and livestock probiotic development. With a mission to build health from the inside out, the company targets overall microbiome health to support all animal body systems and functions. CanBiocin began as a University of Alberta spin-off company and first commercialized Micocin®, a probiotic metabolite used to inhibit the growth of Listeria monocytogenes in processed meat products and with beneficial application in livestock feed. Today, it's premium canine and other pet probiotic lines help global pet food manufacturers fill their customers’ need to care for their pets as integral members of their families deserving of the same attention and investment in their health and wellness. CanBiocin has a growing number of customers in North America, as well as internationally.
Founded in 2013, by Steve Kazemi, Pure Cultures species-specific probiotics and signature products Flock Vitality® and Pig Vitality™ deliver prebiotics, probiotics and postbiotics, to support the growth and health of animals. These products meet consumer and industry
demand to eliminate the over-use of antibiotics in production animals.
CanBiocin Inc. to be one of 12 emerging companies to speak at upcoming VetHealth Global Conference.
CanBiocin Inc., will be one of 12 Emerging International Companies to speak at upcoming VetHealth Global International Animal Health and Nutrition Business Conference this June in Charlottetown, PEI (https://vethealthglobal.com/). CanBiocin has been selected out of over 200 applicants from around the world. Along with the other 11 emerging companies, CanBiocin will provide a presentation on their company during the Innovative Spotlight Series at the conference. This Innovation Spotlight Series was set up to educate and discuss new exciting technologies within the Veterinary World.
Please click below link to see more information about the conference:
Natural Products Canada invests in CanBiocin Inc.
We have been featured in an Xtalks article for companies Natural Products Canada has invested in recently. Thank you for the recognition!
CanBiocin receives AAFCO Certification
We are proud to announce that we are officially AAFCO certified! Given the strict guidelines set by the association, we are more than happy to be a part of an association that takes quality assurance to a whole new level.
Pet Food Forum, Kansas City
We’re at the Pet Food Forum here in Kansas City! It’s amazing to see the possibilities that we can achieve by working together. We’re so excited to meet each one of you!
Growing Strong with Natural Products Canada
We are proud to announce our new partnership with Natural Products Canada! It has been an exciting journey but we would not have been able to reach this significant milestone without the help of everyone around us. We thank you deeply for your efforts!